$CHRS News Article - Junshi Biosciences and Coheru
Post# of 55
(Total Views: 193)
Posted On: 03/15/2022 12:10:55 PM
$CHRS News Article - Junshi Biosciences and Coherus Announce Presentation of Positive Results from CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer, at March ASCO Plenary Series https://marketwirenews.com/news-releases/juns...74195.html
(0)
(0)Coherus BioSciences Inc. (CHRS) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼